Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include COVID-19 and healthcare impacts, Global Cancer Incidence and Screening, COVID-19 Clinical Research Studies, and Lung Cancer Diagnosis and Treatment.
Evolving trends in lung cancer risk factors in the ten most populous countries: an analysis of data from the 2019 Global Burden of Disease Study
HER2 alterations across solid tumors: implications for comprehensive testing
Evolving Global Trends in Prostate Cancer: Disparities Across Income Levels and Geographic Regions (1990-2019)
Does a “Western Lifestyle” Confer a Higher Burden of Colorectal Cancer? A Comparison of EU15+ Countries versus Global Trends between 1990 and 2019
Burden of AML, 1990-2019: Estimates From the Global Burden of Disease Study
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium
Trends in Lung Cancer Incidence and Mortality (1990-2019) in the United States: A Comprehensive Analysis of Gender and State-Level Disparities
Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study
Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19
Trends of kidney cancer burden from 1990 to 2019 in European Union 15 + countries and World Health Organization regions
Trends in prostate cancer mortality in the United States of America, by state and race, from 1999 to 2019: estimates from the centers for disease control WONDER database
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study
Implementation Challenges and Disparities in Molecular Testing for Patients With Stage IV NSCLC: Perspectives from an Urban Safety-Net Hospital
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
Code status and outcomes in patients with cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) registry analysis.
The role of peroxisome proliferator-activated receptors (PPAR) in immune responses
Catheter Ablation for Atrial Fibrillation in Patients With Concurrent Heart Failure